Your browser doesn't support javascript.
loading
COVID-19 vaccine-related frequently asked questions (FAQs) by people with epilepsy and carers in Iran; educational video is included.
Asadi-Pooya, Ali A; Karimi, Afrooz; Razavizadegan, Seyed Mohammad Ali; Ashjazadeh, Nahid; Nemati, Hamid.
Afiliação
  • Asadi-Pooya AA; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, USA. Electronic address: aliasadipooya@yahoo.com.
  • Karimi A; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Razavizadegan SMA; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Ashjazadeh N; Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Nemati H; Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Epilepsy Behav ; 133: 108763, 2022 08.
Article em En | MEDLINE | ID: mdl-35696935
ABSTRACT

OBJECTIVE:

The aim of the current study was to inquire the questions and concerns of people with epilepsy (PWE) about COVID-19 vaccines in order to provide a more realistic list of their frequently asked questions (FAQs).

METHODS:

We surveyed all the consecutive PWE or their care-givers who were referred to our neurology clinics (Shiraz University of Medical Sciences) during January-February 2022. We collected their questions and concerns in relation to COVID vaccines based on a predesigned brief questionnaire. Informed consent to participate in the study was obtained from the participants.

RESULTS:

In total, 452 people participated in the study; 291 people (64.4%) did not have any questions or concerns with regard to the COVID-19 vaccination. Having any questions or concerns about COVID-19 vaccination was significantly associated with not being vaccinated. Questions and concerns about the adverse effects of COVID-19 vaccines [seizure worsening, general adverse effects, long-term effects (e.g., infertility, cognitive dysfunction)] were by far the most common questions by people with epilepsy and their carers.

CONCLUSION:

Our findings may be used by policy-makers to prepare appropriate educational materials to provide the best targeted and tailored information to people with epilepsy and their carers to convince them of the necessity and safety of COVID-19 vaccination. Such an educational material must include enough information on the associated adverse effects of COVID-19 vaccines and should also discuss some other important issues such as indications of these vaccines in special populations and drug-vaccine interactions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Epilepsia / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Epilepsia / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article